Epistemis

Positional pericardial pain

Specialty: Cardiovascular.

  • chest pain of pericardial origin
  • acute pericarditis pain that improves when leaning forward

Why it occurs

  • Acute viral or idiopathic pericarditis
  • Post-traumatic inflammatory pericardial effusion
  • Acute myopericarditis
  • Uremic pericarditis associated with acute or chronic renal failure
  • Secondary pericardial neoplastic involvement (metastasis from lung or breast cancer)

Initial workup

12-lead electrocardiogram (search for diffuse ST segment elevation with superior concavity, PR segment depression, or generalized low voltage); Transthoracic echocardiogram to quantify the volume of the effusion, rule out signs of diastolic collapse of the right ventricle, and evaluate respiratory excursion of the interventricular septum; Quantitative serum determination of inflammatory markers (high-sensitive C-reactive protein, erythrocyte sedimentation rate) and cardiac enzymes (high-sensitivity troponin I) to assess associated myopericarditis.

red flags

Oppressive or stabbing retrosternal pain that worsens in the supine position and improves noticeably when leaning forward (Mohammedan position), of increasing intensity that is accompanied by severe arterial hypotension, jugular engorgement evident on physical examination, paradoxical pulse, extreme compensatory tachycardia (>120 bpm), severe dyspnea at rest or loss of consciousness. These signs warn of the progression from pericarditis to tension effusion and cardiac tamponade requiring immediate surgical resolution.

Standard management

  • Ibuprofen — non-steroidal anti-inflammatory indicated in acute idiopathic or viral pericarditis; 600 mg every 8 hours orally, fixedly prescribed for 10 to 14 days with subsequent gradual tapering and use of gastric mucosal protector
  • Colchicine — anti-inflammatory indicated synergistically to enhance the therapeutic response and prevent recurrences; 0.5 mg daily or twice a day depending on body weight, for 3 months
  • Acetylsalicylic acid — of choice in post-infarction pericardial pain; 500 to 1000 mg every 8 hours orally, discontinuing the use of other NSAIDs
  • Prednisone (second-line systemic glucocorticoid indicated if NSAIDs and colchicine fail or if there is confirmed immune-mediated etiology; 0.2 to 0.5 mg/kg/day orally, with very slow gradual tapering to avoid relapses).

Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.

Area
Cardiovascular
Listed causes
5
Treatment options
4
Download Epistemis